Key Points
- Richard Schapiro, a Molina Healthcare director, sold 357 shares on November 24 at an average price of $143.02 for proceeds of $51,058, reducing his position by 3.05% to 11,352 shares (worth about $1.62M).
- Q3 earnings missed: Molina reported EPS of $1.84 versus a $3.97 consensus while revenue rose 11% to $11.48B; the company set FY2025 guidance at 14.00 EPS and analysts have a consensus "Hold" with a $198.93 target.
- Stock and valuation context: MOH has a market cap of $7.87B, a P/E of 9.0, 50-/200-day moving averages of $171.42/$210.87, a 12-month range of $133.40–$359.97, and opened at $145.29 on Tuesday.
Molina Healthcare, Inc (NYSE:MOH - Get Free Report) Director Richard Schapiro sold 357 shares of the stock in a transaction on Monday, November 24th. The shares were sold at an average price of $143.02, for a total transaction of $51,058.14. Following the sale, the director directly owned 11,352 shares of the company's stock, valued at $1,623,563.04. The trade was a 3.05% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Molina Healthcare Price Performance
MOH stock opened at $145.29 on Tuesday. The stock has a market capitalization of $7.87 billion, a price-to-earnings ratio of 9.00 and a beta of 0.55. The firm's 50-day moving average price is $171.42 and its two-hundred day moving average price is $210.87. The company has a current ratio of 1.68, a quick ratio of 1.68 and a debt-to-equity ratio of 0.92. Molina Healthcare, Inc has a 12-month low of $133.40 and a 12-month high of $359.97.
Molina Healthcare (NYSE:MOH - Get Free Report) last posted its earnings results on Wednesday, October 22nd. The company reported $1.84 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.97 by ($2.13). Molina Healthcare had a return on equity of 22.95% and a net margin of 1.98%.The business had revenue of $11.48 billion during the quarter, compared to the consensus estimate of $10.99 billion. During the same period in the previous year, the business earned $6.01 earnings per share. The firm's revenue for the quarter was up 11.0% compared to the same quarter last year. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. As a group, equities analysts predict that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.
Institutional Investors Weigh In On Molina Healthcare
Several hedge funds have recently bought and sold shares of the business. Zions Bancorporation National Association UT purchased a new position in shares of Molina Healthcare during the first quarter valued at approximately $29,000. Elequin Capital LP increased its position in Molina Healthcare by 170.6% during the 1st quarter. Elequin Capital LP now owns 92 shares of the company's stock valued at $30,000 after buying an additional 58 shares in the last quarter. First Horizon Advisors Inc. raised its stake in Molina Healthcare by 2,140.0% during the second quarter. First Horizon Advisors Inc. now owns 112 shares of the company's stock valued at $33,000 after buying an additional 107 shares during the last quarter. Bogart Wealth LLC bought a new stake in Molina Healthcare in the third quarter worth $39,000. Finally, CYBER HORNET ETFs LLC bought a new stake in Molina Healthcare in the second quarter worth $45,000. Institutional investors own 98.50% of the company's stock.
Analyst Ratings Changes
A number of analysts recently commented on the company. Morgan Stanley set a $158.00 price target on Molina Healthcare in a research note on Friday, October 24th. The Goldman Sachs Group dropped their target price on shares of Molina Healthcare from $207.00 to $167.00 and set a "neutral" rating for the company in a research report on Friday, October 24th. Cantor Fitzgerald reduced their price target on shares of Molina Healthcare from $210.00 to $180.00 and set a "neutral" rating on the stock in a research report on Friday, October 24th. Weiss Ratings restated a "sell (d+)" rating on shares of Molina Healthcare in a report on Wednesday, October 8th. Finally, Truist Financial set a $175.00 price objective on Molina Healthcare in a research report on Friday, October 24th. Three research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $198.93.
Get Our Latest Analysis on Molina Healthcare
About Molina Healthcare
(
Get Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
